Life Sciences BC

#LSBCmember NEWS: Third Year in a Row, LifeLabs Named by Forbes as one of Canada’s Best Employers for Diversity Read more here: https://lnkd.in/gC3_2g4c

LSBC JOB BOARD: Genome British Columbia is hiring a Corporate Relations Manager. Learn more about the role here: https://lnkd.in/gDx4KcwP

LSBC JOB BOARD: PHARMA INVENTOR INC. is looking to hire for multiple research positions. Learn more and apply here: https://lnkd.in/eNHhYG7a

#LSBCmember NEWS: WELL Health Technologies Corp. (TSX: WELL) Announces Approval for Historic $44M Project, the Largest DIGITAL Project Ever Awarded to Advance AI-powered Tech Enablement for Care Providers Read more here: https://lnkd.in/gv5vWnGS

LSBC JOB BOARD: Genevant Sciences is hiring a Senior Manager, Internal LNP Manufacturing. Learn more and apply here: https://lnkd.in/gErgJQTc

Grab your tickets for the 2024 LSBC Awards Gala before July 14 to take advantage of early bird pricing! Taking place on September 10, 2024, this illustrious event brings together members of the life sciences community for an evening celebrating the best in our sector, from influential leaders to innovative organizations. Join us to form connections, reflect on the year so far, and recognize the outstanding achievements of BC's life sciences. Learn more and register here: https://lnkd.in/gsxFjsRM #LSBCawards

#LSBCmember NEWS: AbbVie Announces Appointment of Roopal Thakkar, M.D. as Executive Vice President, Research & Development and Chief Scientific Officer Read more here: https://lnkd.in/gDJ56WQA

Submit your applications by July 31 to join our 2025 Investor Readiness Program (IRP)! The program pairs early-stage SMEs with our entrepreneurs-in-residence for 6 months of invaluable mentorship and education. IRP is the only program of its kind specifically tailored for life sciences companies, featuring mentors experienced in the sector, educational workshops, goal discussions, peer feedback, and conference opportunities. Find program details and apply here: https://lnkd.in/gddtPJAq

The Government of BC released a 2023-2024 Progress Report spotlighting actions taken towards the Life Sciences and Biomanufacturing Strategy. Over the past year a robust foundation has been laid across the five pillars set out in the strategy, positioning BC for development into a global life sciences and biomanufacturing hub. Nearly $2 billion has been invested to help BC’s life sciences sector improve access to talent, support local company growth, increase biomanufacturing capacity, expand clinical trials and commercialize research. Find the full report here: https://lnkd.in/gUYyVeYQ

Exciting news for Aspect Biosystems! We were delighted to attend today's announcement of a $72.75 million investment from the Government of Canada and the Government of BC towards Aspect's $200 million project to develop a world-class biomanufacturing facility, advance its cutting-edge technology platform and expand its therapeutic pipeline of novel bioprinted tissue therapeutics for serious metabolic and endocrine diseases. This important initiative will be Canada's first clinical biomanufacturing facility dedicated to manufacturing next-gen bioprinted tissue therapeutics. Find the full announcement here: https://ow.ly/Ilyr50SzaYP